Mean platelet volume, an indicator of platelet activation, is increased in patients with mitral stenosis and sinus rhythm

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 69, Issue 6, 2009, Pages 708-712

  Varol, Ercan ^a   Ozaydin, Mehmet ^a   Trker, Yasin ^b   Alaca, Sule ^a  

^a SULEYMAN DEMIREL UNIVERSITY   (Turkey)

^b Gulkent Hospital   (Turkey)

Author keywords

Embolism; Mean platelet volume; Mitral stenosis; Platelet function; Sinus rhythm

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MITRAL VALVE STENOSIS; PRIORITY JOURNAL; SINUS RHYTHM; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION; THROMBOCYTE VOLUME; THROMBOEMBOLISM;

ADULT; ARRHYTHMIAS, CARDIAC; BLOOD PLATELETS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MITRAL VALVE STENOSIS; ORGAN SIZE; PLATELET ACTIVATION;

MOROCCAN PEPPER VIRUS;

EID: 70949100865     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365510903007000     Document Type: Article

References (36)

1. Wolf PA, Dawber TT, Thomas HE Jr, K annel WB. Epidemiologic assessment of chronic atrial fi brillation and risk of stroke: Framingham Study. Neurology. 1978;28:973-977
2. Kunishima S, H attor M, K obayashi S, H attori H, I wama Y, Imai Y, Ogawa K, Naoe T, Ohno R. Activation and destruction of platelets in patients with rheumatic heart disease. Eur Heart J. 1994;15:335-338
3. Steele PP, Weily HS, D avies H, Genton E. Platelet survival in patients with rheumatic heart disease. N Engl J Med. 1974;290:537-539
4. Zaki A, S alama M, M asry ME, A bou-Freikha M, Abou-Ammo D, Sweelum M, Mashhour E, Elhendy A. Immediate effect of balloon valvuloplasty on hemostatic changes in mitral stenosis. Am J Cardiol. 2000;85:370-375
5. Chen MC, C hang HW, J uang SS, Y ip HK, W u CJ. I ncreased plasma levels of soluble P-selectin in rheumatic mitral stenosis. Chest. 2004;126:54-58
6. Chen MC, W u CJ, Y ip HK, C hang HW, F ang CY, Y u TH, Fu M. Left atrial platelet activity with rheumatic mitral stenosis: correlation study of severity and platelet P-selectin expression by fl ow cytometry. Chest. 2003;124:1663-1669
7. Topaloglu S, B oyaci A, A yaz S, Y ilmaz S, Y anik O, O zdemir O, Soylu M, Demir AD, Aras D, Kisacik HL, Korkmaz S. Coagulation, fi brinolytic system activation and endothelial dysfunction in patients with mitral stenosis and sinus rhythm. Angiology. 2007;58:85-91.
8. Boyaci A, T opaloglu S, Y ilmaz S, Yanik O, O zdemir O, Demir AD, Aras D, Kisacik H, Korkmaz S. Regional left atrial coagulation and fi brinolytic activities in patients with mitral stenosis. Jpn Heart J. 2004;45:779-788
9. Tengiz I, E rcan E, S ahin F, A lioglu E, D uman C, S aydam G, Buyukkececi F. Presence of factors that activate platelet aggregation in mitral stenotic patients' plasma. Curr Control Trials Cardiovasc Med. 2005;6:2.
10. Smith RL, B lick EF, C oalson J, S tein PD. Thrombus production by turbulence. J Appl Physiol. 1972;32:261-264
11. Stein PD, Sabbah HN. M easured turbulence and its effect on thrombus formation. Circ Res. 1974;35:608-614
12. Stein PD, Sabbah HN. T urbulence blood fl ow in the ascending aorta of humans with normal and diseased aortic valves. Circ Res. 1976;39:58-65.
13. YU SK, Latour JG, M archandise B, Bois B. S hear stressinduced changes in platelet reactivity. Thromb Haemost. 1978;40:551-560
14. Park Y, Schoene N, Haris W. M ean platelet volume as an indicator of platelet activation: methodological issues. Platelets. 2002;13:301-306
15. Boos CJ, L ip GY. A ssessment of mean platelet volume in coronary artery disease - what does it mean? Thromb Res. 2007;120:11-13
16. Martin JF, Trowbridge EA, Salmon GL, Plumb J. The biological signifi cance of platelet volume: its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res. 1983;32:443-460
17. Jakubowski JA, T hompson CB, V aillancourt R, Valeri CR, Deykin D. Arachidonic acid metabolism by platelets of differing size. Br J Haematol. 1983;5:503-511
18. Giles H, Smith REA, Martin JF. Platelet glycoprotein IIb- IIIa and size are increased in acute myocardial infarction. Eur J Clin Invest. 1994;24:69-72.
19. Alyan O, M etin F, K acmaz F, O zdemir O, M aden O, Topaloglu S, Demir AD, Karahan Z, Karadede A, Ilkay E. High levels of high sensitivity C-reactive protein predict the progression of chronic rheumatic mitral stenosis. J Thromb Thrombolysis. 2008; 12 July [Epub ahead of print] .
20. Sahn DJ, D eMaria A, K isslo J, Weyman A. R ecommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978;58:1072-1083
21. Hatle L, Angelsen B, Tromsdal A. N oninvasive assessment of atrioventricular pressure half-time by Doppler ultrasound. Circulation. 1979;60:1096-1104
22. Atak R, Y etkin E, Y etkin O, A yaz S, Ileri M, S enen K, Turhan H, Erbay AR, Cehreli S. Increased systemic and regional coagulation activity in patients with mitral stenosis and sinus rhythm. Angiology. 2003;54:593-597
23. Ileri M, B uyukasik Y, I leri NS, H aznedaroglu IC, G oksel S, Kirazli S, Dundar S. Activation of blood coagulation in patients with mitral stenosis and sinus rhythm. Am J Cardiol. 1998;81:795-797
24. Chen MC, W u CJ, C hang HW, Y ip HK, C hen YH, Cheng CI, Chai HT. Mechanism of reducing platelet activity by percutaneous transluminal mitral valvuloplasty in patients with rheumatic mitral stenosis. Chest. 2004;125:1629-1634
25. Kario K, M atsuo T, N akao K. C igarette smoking increases the mean platelet volume in elderly patients with risk factors for atherosclerosis. Clin Lab Haematol. 1992;14:281-287
26. Papanas N, Symeonidis G, Maltezos E, Mavridis G, Karavageli E, Vosnakidis T, Lakasas G. Mean platelet volume in patients with type 2 diabetes mellitus. Platelets. 2004;15:475-478
27. Coban E, O zdogan M, Y azicioglu G, Akcit F. T he mean platelet volume in patients with obesity. Int J Clin Pract. 2005;59:981-982
28. Nadar S, B lann AD, L ip GY. P latelet morphology and plasma indices of platelet activation in essential hypertension: effects of amlodipine-based antihypertensive therapy. Ann Med. 2004;36:552-557
29. Pathansali R, Smith N, Bath P. Altered megakaryocyte- platelet haemostatic axis in hypercholesterolaemia. Platelets. 2001;12:292-297
30. Debili N, Masse JM, Katz A, Guichard J, Breton-Gorius J, Vainchenker W. Effects of the recombinant hematopoietic growth factors interleukin-3, interleukin-6, stem cell factor, and leukemia inhibitory factor on the megakaryocytic differentiation of CD34s? cells. Blood. 1993;82:84-95.
31. Burstein SA, D owns T, Friese P, L ynam S, Anderson S, Henthorn J, Epstein RB, Savage K. Thrombocytopoiesis in normal and sublethally irradiated dogs: response to human interleukin-6. Blood. 1992;80:420-428
32. Brown AS, Hong Y, d e Belder A, B eacon H, B eeso J, Sherwood R, Edmonds M, Martin JF, Erusalimsky JD. Megakaryocyte ploidy and platelet changes in human diabetes and atherosclerosis. Arterioscler Thromb Vasc Biol. 1997;17:802-807
33. Chang CJ, Hsu LA, Chiang CW, Ko YS, See LC, Shen YC, Ko YL, Kou CT, Lee YS, Pang JH. Percutaneous transvenous mitral valvulotomy normalizes elevated circulating levels of tumor necrosis factor-alpha and interleukin-6 in mitral stenosis with heart failure. Am J Cardiol. 2003;91:1018-1020
34. A, Papathanasiou S, T ousoulis D, T entolouris K, Vasiliadou K, Antoniades C, Latsios G, Stefanadis C. Left atrial function, cytokines and soluble apoptotic markers in mitral stenosis: effects of valvular replacement. Int J Cardiol. 2005;99:111-115
35. Bath PM, Butterworth RJ. Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis. 1996;7:157-161
36. Endler G, Klimesch A, Sunder-Plassmann H, Schillinger M, Exner M, Mannhalter C, Jordanova N, Christ G, Thalhammer R, Huber K, Sunder-Plassmann R. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol. 2002;117:399-404.